As people with HIV live longer, diabetes is becoming an increasingly important contributor to morbidity and mortality, ...
A DeKalb County mother says an urgent care clinic never contacted her family after her teenage daughter’s HIV test came back ...
Some HIV prevention grants have been reduced under Trump, and some Atlanta advocates say they have already seen delays in funds arriving.
The latest outbreak linked to a Karachi hospital is the newest in a series that experts say reflects systemic failures.
Millions of HIV/AIDS patients, many of them in Africa, face an uncertain future as a financial cliff-edge for US-funded ...
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...
An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus ...
Share on Pinterest A drug used to treat HIV infections can also effectively prevent them, a new clinical trial demonstrates. Image credit: luza studios/Getty Images. Human immunodeficiency virus (HIV) ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...
For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...
Each time LaTonya looks at framed photos of herself breastfeeding her baby son for the first time, she swells with emotion. As a mother living with HIV in Colorado, it was a moment she wanted to ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...